Menu

Latest news & events

Uyên Châu Nguyên wins UM Dissertation Prize 2025

Uyên Châu Nguyên wins UM Dissertation Prize 2025

29 January 2026

During the Dies Natalis of Maastricht University, Uyên Châu Nguyên received the UM Dissertation Prize 2025.

Read more
Global research network launched to study menopause and heart health

Global research network launched to study menopause and heart health

20 January 2026

Ten international health research funders, including the Dutch Heart Foundation, are investing $10 million in a new global research network to improve early prevention of cardiovascular disease in women. The initiative focuses on understanding how menopause affects heart health and how early intervention can reduce risk.

Read more
More newsMore events
Carim Maastricht
Carim Maastricht

Magdi Nagy

Post doc

Dr. Magdolna Nagy earned her bachelor's and master's degrees in Clinical Laboratory Sciences at the University of Debrecen, Hungary. She completed her PhD at CARIM, under the guidance of Prof. Johan Heemskerk, Prof. Judith Cosemans, and Prof. Steve Watson (Birmingham, UK), focusing on new patwhays in thrombus formation pathways. During her PhD, she made significant contributions to understanding the intricate mechanisms of thrombus formation by better understanding how blood platelet regulate this process in interaction with vessel wall components, the blood plasma and leukocytes.

After her PhD, she joined the group of Prof. Hugo ten Cate and Prof. Henri Spronk at CARIM as postdoctoral fellow in the clinical thrombosis and haemostasis lab. She worked as part of the Cardiovascular Moonshot of RegMed Consortium where she focused on studying the impact of (anti)coagulation on cardiac regenerative therapy aiming to restore the heart function ex vivo.  In 2019, she received a Contrast Young Investigator Grant from the NHS supported CONTRAST Consortium to investigate the role of the intrinsic activation of coagulation in ischemia reperfusion injury in acute ischemic stroke.

Magdolna is currently working as a researcher within the group of Prof Henri Spronk. In 2022, she was awared with the  prestigous Dr E Dekker postdoctoral grant from the Dutch Heart Foundation for her project focusing on unravelling the impact of contact activation pathway in acute ischemic stroke. Furthermore, she is investigating the alteration of coagulation in atrial fibrillation and the roles of coagulation factor XI in heamostasis and beyond.

Magdi nagy

Department of Biochemistry
Universiteitssingel 50, 6229 ER Maastricht
Room number: H1.314
T: +31(0)43 388 42 63

  • 2025
    • Obino, G., Nieddu, G., Nagy, M., Ippel, H., Cubeddu, T., Spronk, H. M. H., Hackeng, T. M., Formato, M., Lepedda, A. J., & Moroni, L. (2025). Marine-derived sulfated polysaccharides enhance hemocompatibility and endothelialization of nanofibrous PCL for vascular graft applications. Cell Biomaterials, 1(10), Article 100155. https://doi.org/10.1016/j.celbio.2025.100155
    • D'Italia, G., Coenen, D. M., Lemmens, T. P., Brandts, L., Wielders, S. J. H., Nagy, M., Mourmans, S. G. J., Achten, A., Al-Abadi, A., Weerts, J., Aizpurua, A. B., van Empel, V., Schroen, B., & Cosemans, J. M. E. M. (2025). Immuno-haemostatic dysregulation in heart failure with preserved ejection fraction. Esc heart failure, 12(5), 3444-3460. https://doi.org/10.1002/ehf2.15361
    • Wang, M., Taha, A., Nagy, M., Raben, J. D., van Noort, R., Volovici, V., Dammers, R., Duncker, D. J., Spronk, H., Ten Cate, H., Dippel, D., Bobi, J., & van Beusekom, H. M. M. (2025). Microvascular Occlusion and Postrecanalization Hyperperfusion in a Swine Model of Acute Ischemic Stroke. Journal of the American Heart Association, 14(18), Article e042663. https://doi.org/10.1161/JAHA.125.042663
    • Baaten, C. C. F. M. J., Wollenhaupt, J., Henning, T. M., Vondenhoff, S., Schröer, J. R., Stamellou, E., Saritas, T., Kurt, B., Boger, L., Antwerpen, A., Hermann, J., Nagy, M., Sternkopf, M., Buhl, E. M., Raffetseder, U., van der Meijden, P. E. J., Kuijpers, M. J. E., Spronk, H. M. H., Schunk, S. J., ... Noels, H. (2025). Impaired Secondary Platelet Response in Chronic Kidney Disease as a Consequence of Prior Platelet Activation. JACC: Basic to Translational Science, 10(9), Article 101355. https://doi.org/10.1016/j.jacbts.2025.101355
    • Barakzie, A., Cavalcante, F., Donkel, S. J., Nagy, M., Dippel, D. W. J., van der Lugt, A., Roos, Y. B. W. E. M., Majoie, C. B. L. M., ten Cate, H., de Maat, M. P. M., Jansen, A. J. G., & CONTRAST Consortium (2025). Association of Fibrinolysis With Acute Ischemic Stroke Outcome in Patients Undergoing Thrombectomy: Modification by Additional Administration of tPA?Stroke: vascular and interventional neurology, 5(4), Article e001574. https://doi.org/10.1161/SVIN.124.001574
    • van Dievoet, M.-A., Baaten, C. C., Nagy, M., David, C., Brusa, D., Dahlqvist, G., Coubeau, L., De Bruyne, R., Jannone, G., Scheers, I., Hermans, C., Tambucci, R., Pirotte, T., de Magnee, C., Sokal, E., Horman, S., Douxfils, J., Heemskerk, J. W., Lisman, T., & Stephenne, X. (2025). Primary hemostasis in children with cirrhosis prior to liver transplantation: key roles of liver disease severity, von Willebrand factor, and platelet count. Journal of Thrombosis and Haemostasis, 23(7), 2297-2313. https://doi.org/10.1016/j.jtha.2025.04.010
    • Gomez-Rosas, P., Nagy, M., Spronk, H. M. H., Russo, L., Gamba, S., Tartari, C. J., Bolognini, S., Ticozzi, C., Schieppati, F., Sarmiento, R., De Braud, F., Masci, G., Tondini, C., Petrelli, F., Giuliani, F., D'Alessio, A., Santoro, A., Gasparini, G., Labianca, R., ... HYPERCAN Investigators (2025). Activated factor XI–antithrombin and thrombin–antithrombin complexes in the prediction of venous thromboembolism and mortality in patients with non–small-cell lung cancer. Journal of Thrombosis and Haemostasis, 23(6), 1908-1919. https://doi.org/10.1016/j.jtha.2025.02.029
    • Taha, A., Nagy, M., Hund, H. M., van Doormaal, P. J., van Noorden, K., Spronk, H. M. H., Ceulemans, A., van Oostenbrugge, R. J., Duncker, D. J., ten Cate, H., Dippel, D., van Es, A. C. G. M., Bobi, J., & van Beusekom, H. M. M. (2025). Vascular injury and occurrence of microthrombi after endovascular therapy for acute ischaemic stroke in a thromboembolic model. BMJ Neurology Open, 7(1), Article e000989. https://doi.org/10.1136/bmjno-2024-000989
    • Nagy, M., Bender, M., Poulter, N. S., Pike, J. A., Sickmann, A., Vondenhoff, S., Bielicka, N., van Zandvoort, M. A. M. J., Koenen, R. R., ten Cate, H., Stéphenne, X., Heemskerk, J. W. M., & Baaten, C. C. F. M. J. (2025). Formation of tight junction-like structures of zonula occludens 2 in platelet–platelet interaction. Research and practice in thrombosis and haemostasis, 9(3), Article 102845. https://doi.org/10.1016/j.rpth.2025.102845
    • Ceulemans, A., Barakzie, A., Spronk, H. M. H., de Maat, M. P. M., van Beusekom, H. M. M., Taha, A., Emmer, B. J., Roos, Y. B. W. E. M., Dippel, D. W. J., Majoie, C. B. L. M., van Zwam, W. H., ten Cate, H., van Oostenbrugge, R. J., & Nagy, M. (2025). Association between coagulation activity and clinical and imaging outcomes in acute ischemic stroke patients - A sub-study of the MR CLEAN NO-IV trial. Thrombosis Research, 245, Article 109212. https://doi.org/10.1016/j.thromres.2024.109212
    • van Mourik, D. J. M., Jansen, V. L. B. I., Coppens, M., Middeldorp, S., ten Cate, H., Buller, H. R., Spronk, H. M. H., Nagy, M., & van Mens, T. E. (2025). Intrinsic pathway activation in patients with antiphospholipid syndrome and healthy controls. Research and practice in thrombosis and haemostasis, 9(1), Article 102694. https://doi.org/10.1016/j.rpth.2025.102694
    • Barakzie, A., Jansen, G. A. J., Cavalcante, F., Nagy, M., Dippel, D. W. J., van der Lugt, A., Roos, Y. B. W. E. M., Majoie, C. B. L. M., Cate, H. T., de Maat, M. P. M., & CONTRAST Consortium (2025). Association of primary and secondary hemostasis biomarkers with acute ischemic stroke outcome in patients undergoing thrombectomy, with or without thrombolytics: post hoc analysis of the Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands-NO IV. Journal of Thrombosis and Haemostasis, 23(1), 235-247. https://doi.org/10.1016/j.jtha.2024.10.008
  • 2024
    • Hansildaar, R., Raadsen, R., Gerritsen, M., Nagy, M., Dijkshoorn, B., Spronk, H. M. H., Ten Cate, H., & Nurmohamed, M. T. (2024). Comparative Analysis of Coagulation Activation in Rheumatoid Arthritis Patients Treated With TNF Inhibitors Versus JAK Inhibitors: A Longitudinal Study. Journal of Clinical Rheumatology, 30(8), e166-e171. Article 002136. https://doi.org/10.1097/RHU.0000000000002136
    • Baaten, C. C. F. M. J., Nagy, M., Spronk, H. M. H., Ten Cate, H., & Kietselaer, B. L. J. H. (2024). NETosis in Cardiovascular Disease: An Opportunity for Personalized Antithrombotic Treatments?Arteriosclerosis Thrombosis and Vascular Biology, 44(12), 2366-2370. https://doi.org/10.1161/ATVBAHA.124.320150
    • Ceulemans, A., Spronk, H. M. H., Ten Cate, H., van Zwam, W. H., van Oostenbrugge, R. J., & Nagy, M. (2024). Current and potentially novel antithrombotic treatment in acute ischemic stroke. Thrombosis Research, 236, 74-84. https://doi.org/10.1016/j.thromres.2024.02.009
    • Busch, M. H., Ysermans, R., Aendekerk, J., Timmermans, S. A., Potjewijd, J., Damoiseaux, J., Spronk, H. M. H., Ten Cate, H., Reutelingsperger, C., Nagy, M., & van Paassen, P. (2024). The intrinsic coagulation pathway plays a dominant role in driving hypercoagulability in ANCA-Associated Vasculitis. Blood advances, 8(5), 1295-1304. https://doi.org/10.1182/bloodadvances.2023011937
    • Baaten, C. C. F. M. J., Nagy, M., Bergmeier, W., Spronk, H. M. H., & van der Meijden, P. E. J. (2024). Platelet biology and function: plaque erosion vs. rupture. European Heart Journal, 45(1), 18-31. https://doi.org/10.1093/eurheartj/ehad720
  • 2023
    • Jacobs, L. M. C., Wintjens, M. S. J. N., Nagy, M., Willems, L., ten Cate, H., Spronk, H. M. H., van Kuijk, S. M. J., Ghossein-Doha, C., Netea, M. G., Groh, L. A., van Petersen, A. S., & Warle, M. C. (2023). Biomarkers of sustained systemic inflammation and microvascular dysfunction associated with post-COVID-19 condition symptoms at 24 months after SARS-CoV-2-infection. Frontiers in Immunology, 14(1), Article 1182182. https://doi.org/10.3389/fimmu.2023.1182182
    • Schönichen, C., Montague, S. J., Brouns, S. L. N., Burston, J. J., Cosemans, J. M. E. M., Jurk, K., Kehrel, B. E., Koenen, R. R., Ní Áinle, F., O'Donnell, V. B., Soehnlein, O., Watson, S. P., Kuijpers, M. J. E., Heemskerk, J. W. M., & Nagy, M. (2023). Antagonistic Roles of Human Platelet Integrin αiIbβ3 and Chemokines in Regulating Neutrophil Activation and Fate on Arterial Thrombi under Flow. Arteriosclerosis Thrombosis and Vascular Biology, 43(9), 1700-1712. https://doi.org/10.1161/ATVBAHA.122.318767
    • Nagy, M., Robles, A. P., Visser, M., Koeck, T., ten Cate, V., ten Cate-Hoek, A. J., Schwers, S., Heitmeier, S., ten Cate, H., Wild, P. S., & Spronk, H. M. H. (2023). Predictive value for increased activated factor XI activity in acute venous thromboembolism. Journal of Thrombosis and Haemostasis, 21(6), 1610-1622. https://doi.org/10.1016/j.jtha.2023.02.031
    • Busch, M. H., Timmermans, S. A. M. E. G., Van Kuijk, S. M. J., Aendekerk, J. P., Ysermans, R., Van Doorn, D. P. C., Potjewijd, J., Van de Poll, M. C. G., Van der Horst, I. C. C., Damoiseaux, J. G. M. C., Spronk, H. M. H., Cate, H. T., Reutelingsperger, C. P., Nagy, M., & Van Paassen, P. (2023). Thrombin formation via the intrinsic coagulation pathway and von Willebrand factor reflect disease severity in COVID-19. Haematologica-the Hematology Journal, 108(5), 1417-1422. https://doi.org/10.3324/haematol.2022.281693
    • Beck, S., Öftering, P., Li, R., Hemmen, K., Nagy, M., Wang, Y., Zarpellon, A., Schuhmann, M. K., Stoll, G., Ruggeri, Z. M., Heinze, K. G., Heemskerk, J. W. M., Ruf, W., Stegner, D., & Nieswandt, B. (2023). Platelet glycoprotein V spatio-temporally controls fibrin formation. Nature cardiovascular research, 2(4), 368-382. https://doi.org/10.1038/s44161-023-00254-6
    • Willems, L. H., Jacobs, L. M. C., Groh, L. A., ten Cate, H., Spronk, H. M. H., Wilson-Storey, B., Hannink, G., van Kuijk, S. M. J., Ghossein-Doha, C., Nagy, M., Thijssen, D. H. J., van Petersen, A. S., & Warle, M. C. (2023). Vascular Function, Systemic Inflammation, and Coagulation Activation 18 Months after COVID-19 Infection: An Observational Cohort Study. Journal of Clinical Medicine, 12(4), Article 1413. https://doi.org/10.3390/jcm12041413
    • Iding, A. F. J., Kremers, B. M. M., Nagy, M., Robles, A. P., Ten Cate, H., Spronk, H. M. H., & Ten Cate-Hoek, A. J. (2023). Translational insights into mechanisms underlying residual venous obstruction and the role of factor XI, P-selectin and GPVI in recurrent venous thromboembolism. Thrombosis Research, 221(1), 58-64. https://doi.org/10.1016/j.thromres.2022.11.023
  • 2022
    • Nagy, M., van der Meijden, P. E. J., Glunz, J., Schurgers, L., Lutgens, E., Ten Cate, H., Heitmeier, S., & Spronk, H. M. H. (2022). Integrating Mechanisms in Thrombotic Peripheral Arterial Disease. Pharmaceuticals, 15(11), Article 1428. https://doi.org/10.3390/ph15111428
    • Willems, L. H., Thijssen, D. H. J., Groh, L. A., Kooijman, N. I., Ten Cate, H., Spronk, H. M. H., Donders, A. R. T., Van der Vijver-Coppen, R. J., van Hoek, F., Nagy, M., Reijnen, M. M. P. J., & Warle, M. C. (2022). Dual pathway inhibition as compared to acetylsalicylic acid monotherapy in relation to endothelial function in peripheral artery disease, a phase IV clinical trial. Frontiers in Cardiovascular Medicine, 9, Article 979819. https://doi.org/10.3389/fcvm.2022.979819
    • van de Berg, T. W., Mulder, M. M. G., Alnima, T., Nagy, M., van Oerle, R., Beckers, E. A. M., Hackeng, T. M., Hulshof, A. M., Sels, J. W. E. M., Henskens, Y. M. C., van der Horst, I. C. C., ten Cate, H., Spronk, H. M. H., van Bussel, B. C. T., & Dutch COVID & Thrombosis Coalition (2022). Serial thrombin generation and exploration of alternative anticoagulants in critically ill COVID-19 patients: Observations from Maastricht Intensive Care COVID Cohort. Frontiers in Cardiovascular Medicine, 9, Article 929284. https://doi.org/10.3389/fcvm.2022.929284
    • van den Kerkhof, D. L., Nagy, M., Wichapong, K., Brouns, S. L. N., Suylen, D. P. L., Hackeng, T. M., & Dijkgraaf, I. (2022). Unraveling the role of the homoarginine residue in antiplatelet drug eptifibatide in binding to the αIIbβ3 integrin receptor. Thrombosis Research, 217, 96-103. https://doi.org/10.1016/j.thromres.2022.07.011
    • Nagy, M., & ten Cate, H. (2022). What to expect from drug targeting factor XI?Cardiovascular Research, 118(10), E72-E74. https://doi.org/10.1093/cvr/cvac091
    • Peters, L. J. F., Baaten, C. C. F. M. J., Maas, S. L., Lu, C., Nagy, M., Jooss, N. J., Bidzhekov, K., Santovito, D., Moreno-Andrés, D., Jankowski, J., Biessen, E. A. L., Döring, Y., Heemskerk, J. W. M., Weber, C., Kuijpers, M. J. E., & van der Vorst, E. P. C. (2022). MicroRNA-26b Attenuates Platelet Adhesion and Aggregation in Mice. Biomedicines, 10(5), Article 983. https://doi.org/10.3390/biomedicines10050983
    • Dauwerse, S., ten Cate, H., Spronk, H. M. H., & Nagy, M. (2022). The Composition and Physical Properties of Clots in COVID-19 Pathology. Diagnostics, 12(3), Article 580. https://doi.org/10.3390/diagnostics12030580
    • Spaetgens, B., Nagy, M., & ten Cate, H. (2022). Antiplatelet Therapy in Patients With COVID-19-More Is Less?JAMA-Journal of the American Medical Association, 327(3), 223-224. https://doi.org/10.1001/jama.2021.23866
    • Willems, L. H., Nagy, M., Ten Cate, H., Spronk, H. M. H., Groh, L. A., Leentjens, J., Janssen, N. A. F., Netea, M. G., Thijssen, D. H. J., Hannink, G., van Petersen, A. S., & Warle, M. C. (2022). Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19. Thrombosis Research, 209, 106-114. https://doi.org/10.1016/j.thromres.2021.11.027
  • 2021
    • Willems, L. H., Nagy, M., Ten Cate, H., Spronk, H. M. H., Jacobs, L. M. C., Kranendonk, J., van Leeuwen, M., Meijer, D., Middeldorp, S., Groh, L. A., & Warle, M. C. (2021). ChAdOx1 vaccination, blood coagulation, and inflammation: No effect on coagulation but increased interleukin-6. Research and practice in thrombosis and haemostasis, 5(8), Article e12630. https://doi.org/10.1002/rth2.12630
    • Montague, S. J., Patel, P., Martin, E. M., Slater, A., Quintanilla, L. G., Perrella, G., Kardeby, C., Nagy, M., Mezzano, D., Mendes, P. M., & Watson, S. P. (2021). Platelet activation by charged ligands and nanoparticles: platelet glycoprotein receptors as pattern recognition receptors. Platelets, 32(8), 1018-1030. https://doi.org/10.1080/09537104.2021.1945571
    • Perrella, G., Nagy, M., Watson, S. P., & Heemskerk, J. W. M. (2021). Platelet GPVI (Glycoprotein VI) and Thrombotic Complications in the Venous System. Arteriosclerosis Thrombosis and Vascular Biology, 41(11), 2681-2692. https://doi.org/10.1161/ATVBAHA.121.316108
    • Giesen, P. L. A., Gulpen, A. J. W., van Oerle, R., ten Cate, H., Nagy, M., & Spronk, H. M. H. (2021). Calibrated automated thrombogram II: removing barriers for thrombin generation measurements. Thrombosis Journal, 19(1), Article 60. https://doi.org/10.1186/s12959-021-00312-8
    • Coenen, D. M., Heinzmann, A. C. A., Oggero, S., Albers, H. J., Nagy, M., Hague, P., Kuijpers, M. J. E., Vanderwinden, J. M., van der Meer, A. D., Perretti, M., Koenen, R. R., & Cosemans, J. M. E. M. (2021). Inhibition of Phosphodiesterase 3A by Cilostazol Dampens Proinflammatory Platelet Functions. Cells, 10(8), Article 1998. https://doi.org/10.3390/cells10081998
    • Baidildinova, G., Nagy, M., Jurk, K., Wild, P. S., ten Cate, H., & van der Meijden, P. E. J. (2021). Soluble Platelet Release Factors as Biomarkers for Cardiovascular Disease. Frontiers in Cardiovascular Medicine, 8, Article 684920. https://doi.org/10.3389/fcvm.2021.684920
    • Nagy, M., Fazaeli, S., van Oerle, R., Ten Cate, H., Schemmann, M., Sherry, J., Kelleher, G., & Spronk, H. M. H. (2021). Evaluation of the analytical performance of the PC100 platelet counter. Thrombosis Journal, 19(1), Article 29. https://doi.org/10.1186/s12959-021-00283-w
    • van de Berg, T. W., Hulshof, A.-M. M., Nagy, M., van Oerle, R., Sels, J.-W., van Bussel, B., Ten Cate, H., Henskens, Y., Spronk, H. M. H., & Dutch Covid-19 and Thrombosis Coalition (2021). Suggestions for global coagulation assays for the assessment of COVID-19 associated hypercoagulability. Thrombosis Research, 201, 84-89. https://doi.org/10.1016/j.thromres.2021.02.026
    • van den Kerkhof, D. L., Nagy, M., Wichapong, K., Brouns, S. L. N., Heemskerk, J. W. M., Hackeng, T. M., & Dijkgraaf, I. (2021). Inhibition of platelet adhesion, thrombus formation, and fibrin formation by a potent αIIbβ3 integrin inhibitor from ticks. Research and practice in thrombosis and haemostasis, 5(1), 231-242. https://doi.org/10.1002/rth2.12466
  • 2020
    • Mastenbroek, T. G., Karel, M. F. A., Nagy, M., Chayoua, W., Korsten, E. I. J., Coenen, D. M., Debets, J., Konings, J., Brouns, A. E., Leenders, P. J. A., van Essen, H., van Oerle, R., Heitmeier, S., Spronk, H. M., Kuijpers, M. J. E., & Cosemans, J. M. E. M. (2020). Vascular protective effect of aspirin and rivaroxaban upon endothelial denudation of the mouse carotid artery. Scientific Reports, 10(1), Article 19360. https://doi.org/10.1038/s41598-020-76377-8
    • Busch, M. H., Timmermans, S. A. M. E. G., Nagy, M., Visser, M., Huckriede, J., Aendekerk, J. P., de Vries, F., Potjewijd, J., Jallah, B., Ysermans, R., Oude Lashof, A. M. L., Breedveld, P. H., van de Poll, M. C. G., van de Horst, I. C. C., van Bussel, B. C. T., Theunissen, R. O. M. F. I. H., Spronk, H. M. H., Damoiseaux, J. G. M. C., ten Cate, H., ... van Paassen, P. (2020). Neutrophils and Contact Activation of Coagulation as Potential Drivers of COVID-19. Circulation, 142(18), 1787-1790. https://doi.org/10.1161/CIRCULATIONAHA.120.050656
    • Heinzmann, A. C. A., Karel, M. F. A., Coenen, D. M., Vajen, T., Meulendijks, N. M. M., Nagy, M., Suylen, D. P. L., Cosemans, J. M. E. M., Heemskerk, J. W. M., Hackeng, T. M., & Koenen, R. R. (2020). Complementary roles of platelet αIIbβ3 integrin, phosphatidylserine exposure and cytoskeletal rearrangement in the release of extracellular vesicles. Atherosclerosis, 310, 17-25. https://doi.org/10.1016/j.atherosclerosis.2020.07.015
    • Nagy, M., Perrella, G., Dalby, A., Becerra, M. F., Quintanilla, L. G., Pike, J. A., Morgan, N., Gardiner, E. E., Heemskerk, J. W. M., Azocar, L., Miquel, J. F., Mezzano, D., & Watson, S. P. (2020). Flow studies on human GPVI-deficient blood under coagulating and noncoagulating conditions. Blood advances, 4(13), 2953-2961. https://doi.org/10.1182/bloodadvances.2020001761
    • Sternkopf, M., Nagy, M., Baaten, C. C. F. M. J., Kuijpers, M. J. E., Tullemans, B. M. E., Wirth, J., Theelen, W., Mastenbroek, T. G., Lehrke, M., Winnerling, B., Baerts, L., Marx, N., De Meester, I., Doring, Y., Cosemans, J. M. E. M., Daiber, A., Steven, S., Jankowski, J., Heemskerk, J. W. M., & Noels, H. (2020). Native, Intact Glucagon-Like Peptide 1 Is a Natural Suppressor of Thrombus Growth Under Physiological Flow Conditions. Arteriosclerosis Thrombosis and Vascular Biology, 40(3), E65-E77. https://doi.org/10.1161/atvbaha.119.313645
    • Onselaer, M.-B., Nagy, M., Pallini, C., Pike, J. A., Perrella, G., Quintanilla, L. G., Eble, J. A., Poulter, N. S., Heemskerk, J. W. M., & Watson, S. P. (2020). Comparison of the GPVI inhibitors losartan and honokiol. Platelets, 31(2), 187-197. https://doi.org/10.1080/09537104.2019.1585526
  • 2019
    • van Geffen, A., Brouns, S., Batista, J., McKinney, H., Kempster, C., Nagy, M., Sivapalaratnam, S., Baaten, C., Bourry, N., Frontini, M., Jurk, K., Krause, M., Pilliteri, D., Swieringa, F., Verdoold, R., Cavill, R., Kuijpers, M., Ouwehand, W. H., Downes, K., & Heemskerk, J. (2019). High-throughput elucidation of thrombus formation reveals sources of platelet function variability. Haematologica-the Hematology Journal, 104(6), 1256-1267. https://doi.org/10.3324/haematol.2018.198853
Overview